Parallel Bio is pioneering human-first drug discovery using proprietary organoids at scale and ML to model complex diseases and discover drug candidates with a significantly higher probability of clinical success. Parallel Bio’s immune organoid platform rapidly, reliably, and cost effectively predicts drug safety & efficacy using the real diversity of human beings.